Alternative Pathway Complement Activation and Low Circulating Inhibitors Associate With Severity and Mortality in COVID-19 and Non-COVID Sepsis
N.J. Meyer, K. Devalaraja-Narashimha, K. Laudanski, P. Ehmann, S. Afolayan, S. DerOhannessian, G. Spade, C.A.G. Ittner, A.P. Turner, M. Esperanza, T.G. Dunn, J.-A.A. Ko, J. Weaver, P. PennMedicine Biobank, O. Zhu, D. Scott, S. Hamon, A. Wistermayer, L. Hersch, A. Hooper, M. Burczynski, D. Glass, J. Hamilton, T.K. Jones, H.M. Giannini, M.G.S. Shashaty, J.P. Reilly, L. Morton, G.A. FitzGerald, D.J. Rader A103. DYSREGULATED PATHWAYS IN SEPSIS AND LUNG INJURY: SEARCHING FOR TREATABLE TRAITS（2024）
AI 理解论文
溯源树
样例
